Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications Publication Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications Danielle Pillsbury2017 年 5 月 1 日
CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites Publication CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites Danielle Pillsbury2017 年 3 月 1 日
Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer Publication Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer Danielle Pillsbury2016 年 12 月 18 日
Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models Publication Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models Danielle Pillsbury2016 年 10 月 5 日
Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains Publication Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains Danielle Pillsbury2016 年 10 月 1 日
Population Pharmacokinetics of Bevacizumab in Cancer Patients with External Validation Publication Population Pharmacokinetics of Bevacizumab in Cancer Patients with External Validation Danielle Pillsbury2016 年 8 月 1 日
Physiologically-based Pharmacokinetic Modeling in Pediatric Oncology Drug Development Publication Physiologically-based Pharmacokinetic Modeling in Pediatric Oncology Drug Development Danielle Pillsbury2016 年 7 月 1 日
Lessons Learned: Dose Selection of Small Molecule-targeted Oncology Drugs Publication Lessons Learned: Dose Selection of Small Molecule-targeted Oncology Drugs Danielle Pillsbury2016 年 6 月 1 日
Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Kinetics in Medullary Thyroid Cancer Patients Receiving Cabozantinib Publication Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Kinetics in Medullary Thyroid Cancer Patients Receiving Cabozantinib Nonlinear mixed effects models were developed to describe the relationship between cabozantinib exposure and target…Danielle Pillsbury2016 年 4 月 27 日
Breast Cancer Resistance Protein Abundance, but Not mRNA Expression, Correlates with Estron e-3-Sulfate Transport in Caco-2 Publication Breast Cancer Resistance Protein Abundance, but Not mRNA Expression, Correlates with Estron e-3-Sulfate Transport in Caco-2 Transporter mRNA and protein expression data are used to extrapolate in vitro transporter kinetics to in…Danielle Pillsbury2016 年 4 月 1 日